North America was the largest region in the anti-infective drugs market in 2017, accounting for around 30% market share. This can be attributed to the presence of established health care networks and high healthcare spending in the region. Asia Pacific was the second largest region accounting for around 21% market share. Western Europe was the third largest region accounting for around 20% market share.
Anti-infective Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs sector.
Anti-infective Drugs Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the anti-infective drugs market revenues, covering both the historic growth of the market and forecasting the future.
Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.
The trends and strategies section highlights the likely future developments in the anti-infective drugs market and suggests approaches.
Reasons To Purchase
- Fully updated for 2018.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
Markets Covered: Antivirals, Antibiotics, Antifungals, and Others (Antihelmethic, Antiprotozoal).
Companies Mentioned: Gilead Sciences, Inc., Merck & Co., GlaxosmithKline Plc., Bristol-Myers Squibb Company, Johnson & Johnson, Pfizer Inc., AbbVie Inc., Novartis AG, Bayer AG, Otsuka Pharmaceutical Co., Ltd.
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
Table of Contents
Anti-infective Drugs Market Characteristics 5
Anti-infective Drugs Market Historic Growth (2013-17) 7
Anti-infective Drugs Market Forecast Growth (2017-21) 8
Anti-infective Drugs Market Segmentation 9
Global Anti-infective Drugs Market, Split By Segments, 2017, $ Billion 9
Others (Antihelmethic, Antiprotozoal) 10
Global Anti-infective Drugs Market, Historic and Forecast, Split By Segments, 2013-2021 11
Anti-infective Drugs Market Geography Regional and Country Comparison 13
Global Anti-infective Drugs Market, Split By Regions, 2017 13
Global Anti-infective Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021 15
Global Anti-infective Drugs Market, Split By Country, 2017 17
Global Anti-infective Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021 19
Anti-infective Drugs Market Competitive Landscape 21
Merck & Co. 22
Bristol-Myers Squibb Company 22
Johnson & Johnson 22
Novartis AG 22
Bayer AG 22
Merck & Co. 23
Anti-Infective Drug Market Key Mergers and Acquisitions 25
Johnson & Johnson Acquired Alios 25
Pfizer Acquired Small Molecule Anti-Infective Business From AstraZeneca 25
GlaxoSmithKline Acquired Okairos 25
PharmAthene Merged With Altimmune 25
Citius Pharmaceuticals Acquired Leonard-Meron Biosciences 25
Johnson & Johnson Acquired Novira Therapeutics, Inc. 25
Anti-Infective Drug Market Trends and Strategies 26
Strategic Collaborations And Agreements 26
Demand For New Medicines For Drug-Resistant Infections 26
New Drug Innovations 26
NAICS Definitions Of Industry Covered In This Report 27
Definition Of Market Covered In This Report 27
Research Methodology 28
Research Inquiries 29
The Business Research Company 29
List of Figures
Figure 1: Global Anti-infective Drugs Market, Historic Market Size, 2013-2017, $ Billion 7
Figure 2: Global Anti-infective Drugs Market, Forecast Market Size, 2017 – 2021, $ Billion 8
Figure 3: Global Anti-infective Drugs Market, Split By Segments, 2017, $ Billion 9
Figure 4: Global Anti-infective Drugs Market, Historic and Forecast, Split By Segment, 2013 – 2021 11
Figure 5: Global Anti-infective Drugs Market, Split By Region, 2017, $ Billion 13
Figure 6: Global Anti-infective Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021 15
Figure 7: Global Anti-infective Drugs Market, Split By Country, 2017, $ Billion 17
Figure 8: Global Anti-infective Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021 19
Figure 9: Global Anti-infective Drugs Market, Key Competitor Estimated Market Shares, 2017, Percentage (%) 21
The Business Research Company
47 Anchorage Point,
42 Cuba Street, Canary Wharf,
+44 207 1930 708